BioWin, CETIC and essenscia wallonie launch BioMan initiative to accelerate digitization of bioprocesses in Wallonia
Nosopharm and GNA Now announce positive results for the late preclinical development of the first-in-class antibiotic NOSO-502
Thabor Therapeutics appoints Jérémie Mariau as CEO
Barbara IoT raises €2.5M in funding from Caixa Capital Risc and Iberdrola
BioWin spearheads ‘Talent Now’, a unique initiative to tackle recruitment shortages and challenges in the healthtech industry
Biomunex unveils MAIT cell redirection approach for lead immune-oncology program at PEGS Boston Conference
AdBio partners welcomes Inserm Transfert as investor in second fund – AFB Fund II
Biomunex appoints Dr. Simon Plyte, PhD, as Chief Scientific Officer to boost clinical and business development
